Maxigen Biotech Inc. (TPE:1783)
Taiwan
· Delayed Price · Currency is TWD 41.50
-1.45 (-3.38%)
Mar 9, 2026, 1:30 PM CST
Maxigen Biotech Revenue
Maxigen Biotech had revenue of 200.86M TWD in the quarter ending September 30, 2025, with 15.47% growth. This brings the company's revenue in the last twelve months to 792.49M, up 27.05% year-over-year. In the year 2024, Maxigen Biotech had annual revenue of 680.65M with 9.41% growth.
Revenue (ttm)
792.49M
Revenue Growth
+27.05%
P/S Ratio
4.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 680.65M | 58.54M | 9.41% |
| Dec 31, 2023 | 622.12M | 17.68M | 2.93% |
| Dec 31, 2022 | 604.43M | 92.46M | 18.06% |
| Dec 31, 2021 | 511.98M | 54.29M | 11.86% |
| Dec 31, 2020 | 457.69M | 5.49M | 1.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ICARES Medicus | 1.09B |
| Nang Kuang Pharmaceutical | 2.16B |
| Bionime | 1.91B |
| SciVision Biotech | 886.62M |
| St.Shine Optical | 4.40B |
| Pacific Hospital Supply | 2.41B |
| Crystalvue Medical | 949.05M |
| Formosa Optical Technology | 3.98B |